ASC (adipose-derived stromal cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASC (adipose-derived stromal cells), covering 2025-12-31 to 2025-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. [Phase 2]